Skip to main content
Category

Funding

New EGFR Resisters Multi-Year Research Partnership with Lung Cancer Research Foundation (LCRF) AdvocacyFundingPartners

New EGFR Resisters Multi-Year Research Partnership with Lung Cancer Research Foundation (LCRF)

*June 2021* The EGFR Resisters is thrilled to announce a new multi-year research partnership with Lung Cancer Research Foundation (LCRF)!  LCRF is a large non-profit lung cancer advocacy organization based in New York whose mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and…
cece
June 24, 2021
EGFR Resisters logo
EGFR Resisters and LUNGevity Foundation Partner on Lung Cancer Research Award FundingPartnersResearchTreatments

EGFR Resisters and LUNGevity Foundation Partner on Lung Cancer Research Award

*February 2021* WASHINGTON, Feb. 19, 2021 /PRNewswire/ -- Patient group EGFR Resisters and LUNGevity Foundation today announced the 2021 recipients of the first EGFR Resisters/LUNGevity Lung Cancer Research Award. This award program, driven by EGFR Resisters—a grassroots patient-led group that has 2,500+ patients and caregivers from 75+ countries—supports critical research that seeks to…
cece
June 19, 2021
dana farber logo
Dana-Farber Cancer Institute to Establish Chen-Huang Center for EGFR Mutant Lung Cancers FundingResearch

Dana-Farber Cancer Institute to Establish Chen-Huang Center for EGFR Mutant Lung Cancers

*January 2020* Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute’s capabilities for studying and treating lung cancer. The Chen-Huang Center is being established with a $5 million gift from Winston Chen,…
laurabbook@gmail.com
January 18, 2020